On Holding (ONON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Pixelworks (PXLW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Parker-Hannifin (PH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Pagaya Technologies Ltd. (PGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TC Energy (TRP) and ONEOK (OKE) are midstream companies that have been moving in different directions in terms of their share prices, resulting in one becoming undervalued. Both names have enjoyed a long history of paying and growing their dividends, and being in the midstream space generally results in higher relative yields as well. While both may be attractive long-term bets, I have recently made a move on OKE and expect my TRP shares to be called away after writing covered calls.

Volatility hit Nvidia (NVDA) late Thursday morning following its earnings report, though Hatem Dhiab sees the company maintaining strength for the long-term. He calls the report "fantastic" and its $500 billion Blackwell guidance "really insane.

Nvidia Corporation delivered strong Q3 '26 earnings, beating expectations and restoring confidence in the AI sector after weeks of market anxiety. NVDA's data center revenue surged 66% year over year, with robust margins and guidance, signaling sustained demand for AI infrastructure. I'm upgrading NVDA stock to a buy as technicals are turning bullish and see a potential for the stock to retest 52-week highs if momentum holds.

Introduces 2028 Financial Targets Reflecting Enhanced Growth and Profitability Announces Plan to Return $10 Billion to Shareholders Through 2028 ST. LOUIS , Nov. 20, 2025 /PRNewswire/ -- Emerson (NYSE: EMR) today hosted its 2025 Investor Conference, during which it outlined its strategic priorities for engineering the autonomous future and introduced new 2028 financial targets.

T. Rowe Price launched four new active fixed income ETFs Thursday, adding to their ever-growing active ETF suite. The four funds include three tax-free ETFs and one “go-anywhere” active bond ETF.

New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

NNE's microreactors are in demand amid the rising clean-energy demand from different customer groups.

ONEOK (OKE) is a major U.S. midstream operator, moving and processing natural gas liquids through a large, fee-based pipeline network that delivers steady cash flow. Despite its scale and stability, the stock hasn't kept pace, creating a potential disconnect between performance and valuation.

Liquidity Services, Inc. ( LQDT ) Q4 2025 Earnings Call November 20, 2025 10:30 AM EST Company Participants Michael Patrick William Angrick - Co-founder, Chairman of the Board of Directors & CEO Jorge Celaya - Chief Financial Officer Conference Call Participants Gary Prestopino - Barrington Research Associates, Inc., Research Division George Sutton - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Welcome to the Liquidity Services Inc., Fourth Quarter of Fiscal Year 2025 financial results conference call. My name is Liz, and I will be your operator for today's call.

Construction Partners, Inc. ( ROAD ) Q4 2025 Earnings Call November 20, 2025 10:00 AM EST Company Participants F. Smith - President, CEO & Director Gregory Hoffman - Senior VP & CFO Ned Fleming - Executive Chairman of the Board Conference Call Participants Rick Black - Dennard Lascar Associates, LLC Kathryn Thompson - Thompson Research Group, LLC Patrick Brown - Raymond James & Associates, Inc., Research Division Michael Feniger - BofA Securities, Research Division Adam Thalhimer - Thompson, Davis & Company, Inc., Research Division Jean Paul Ramirez - D.A.

Magnera Corporation ( MAGN ) Q4 2025 Earnings Call November 20, 2025 10:00 AM EST Company Participants Robert Weilminster - Executive Vice President of Strategy, Integration, Corporate Development & Investor Relations Curtis Begle - CEO, President & Director James Till - Executive VP, CFO & Treasurer Conference Call Participants Richard Carlson - Wells Fargo Securities, LLC, Research Division Kevin McCarthy - Vertical Research Partners, LLC Roger Spitz - BofA Securities, Research Division Edward Brucker - Barclays Bank PLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Magnera Fourth Quarter 2025 Earnings Conference Call.

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Jayud Global Logistics Limited (“Jayud” or the “Company”) (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, inclusive. For more information, submit a form at Jayud Global Logistics Limited Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Novo Nordisk is quietly coming out of the storm despite the prevailing pessimism, especially among retail investors. Thanks to Wegovy's approval as a treatment for NASH, its sales rose to DKK 20.35 billion in the 3rd quarter. Yes, Ozempic remains a "dark spot" in Novo Nordisk's GLP-1 franchise, but at the same time, its sales grew by 3.2% year on year.

Arm Holdings' dual-sided network effect fuels a powerful developer???hardware flywheel that cements its dominance in mobile computing.